Diane Liu, M.S.
Senior Statistical
Analyst
Department of
Biostatistics
The University of Texas
M. D. Anderson
Cancer Center
Some recent
publications in peer-reviewed journals:
- Jeha S, Smith FO, Estey E, Shen Y, Liu D,
Manshouri T, Albitar M.
Comparison between pediatric acute myeloid leukemia (AML) and adult AML in
VEGF and KDR (VEGF-R2) protein levels. Leukemia Research 2002;
26(4):399-402.
- Shin
DM, Glisson BS, Khuri
FR, Clifford JL, Clayman G, Benner SE, Forastiere AA, Ginsberg L, Liu D, Lee JJ, Myers J, Goepfert H, Lotan R, Hong WK, Lippman
SM. Phase II and biologic study of
interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. Journal of
Clinical Oncology 2002; 20(2):364-370.
- Soria JC, Moon C, Wang L, Hittelman
WN, Jang SJ, Sun SY, Lee JJ, Liu D,
Kurie JM, Morice RC,
Lee JS, Hong WK, Mao L. Effects of N-(4-hydroxyphenyl)retinamide
on hTERT expression in the bronchial epithelium
of cigarette smokers. Journal of the National Cancer Institute 2001;
93(16):1257-1263.
- Lee
JJ, Liu D, Lee JS, Kurie JM, Khuri FR, Ibarguen H, Morice RC, Walsh
G, Ro JY, Broxson A, Hong WK, Hittelman WN. Long-term impact of smoking on lung
epithelial proliferation in current and former smokers. Journal of the
National Cancer Institute 2001; 93(14):1081-1088.
- Papadimitrakopoulou VA, Izzo
J, Mao L, Keck J, Hamilton D, Shin DM, El-Naggar
A, den Hollander P, Liu D, Hittelman WN, Hong WK. Cyclin
D1 and p16 alterations in advanced premalignant
lesions of the upper aerodigestive tract: role in response to
chemoprevention and cancer development. Clinical Cancer Research 2001;
7(10):3127-3134.
- Kim
ES, Lu C, Khuri FR, Tonda
M, Glisson BS, Liu D, Jung M, Hong WK, Herbst
RS. A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small
cell lung cancer. Lung Cancer 2001; 34(3):427-432.
- Hassan KA, El-Naggar AK, Soria JC, Liu D,
Hong WK, Mao L. Clinical significance of cyclin
B1 protein expression in squamous cell carcinoma of the tongue. Clinical
Cancer Research 2001; 7(8):2458-2462.
·
Kurie JM, Lee JS, Khuri FR, Mao L, Morice RC, Lee
JJ, Walsh GL, Broxson A, Lippman
SM, Ro JY, Kemp BL, Liu D, Fritsche HA, Xu XC, Lotan R, Hong WK.
N-(4-hydroxyphenyl) retinamide in the
chemoprevention of squamous metaplasia and dysplasia
of the bronchial epithelium. Clinical
Cancer Research 2000; 6(8): 2973-2979.
·
Tang X, Khuri FR, Lee
JJ, Kemp BL, Liu D, Hong WK, Mao L. Hypermethylation of the death-associated protein (DAP)
kinase promoter and aggressiveness in stage I non-small-cell lung cancer.
·
Journal of the National Cancer Institute 2000;
92(18):1511-1516.
·
Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK, Mao L. Overexpression of cyclin B1 in early stage non-small cell lung cancer and its
clinical implication. Cancer Research 2000; 60(15):4000-4004.
·
Herbst RS, Yano S, Kuniyasu H, Khuri FR, Bucana CD, Guo F, Liu D, Kemp BL, Lee JJ, Hong WK, Fidler IJ. Diiferential expression of E-cadherin
and type IV collagenase genes predicts outcome in
patients with stage I non-small cell lung carcinoma. Clinical Cancer Research 2000; 6(3):790-797.
·
Zhou X, Kemp BL, Khuri
FR, Liu D, Lee JJ, Wu W, Hong WK,
Mao L. Prognostic implication of microsatellite alteration profiles in early-stage non-small
cell lung cancer. Clinical Cancer Research 2000; 6(2):559-565.
·
Tseng JE, Rodriguez M, Ro J, Liu D, Hong WK, Mao L. Gender difference in p53 mutational status in
small cell lung cancer. Cancer Research 1999; 59(22):5666-5670.
·
Tseng JE, Kemp BL, Khuri
FR, Kurie JM, Lee JS, Zhou X, Liu D, Hong WK, Mao L. Loss
of Fhit is frequent in stage I non-small cell lung
cancer and in the lungs of chronic smokers. Cancer Research 1999;
59(19):4798–4803.